Literature DB >> 15567647

Vascular endothelial growth factor (VEGF) in plasma increases after hip surgery.

Christer H Svensén1.   

Abstract

STUDY
OBJECTIVE: To determine whether the plasma concentration of vascular endothelial growth factor (VEGF) is elevated after a common surgical procedure, and if any increase is followed by a reduction in the amount of infused crystalloid fluid in the blood.
DESIGN: Nonrandomized study. Experimental group age-matched to control group.
SETTING: Operating room of a large medical research center. PATIENTS: 10 ASA physical status I, II, and III patients, aged 51 to 94 years, scheduled for hip surgery; and 10 ASA physical status I and II volunteers, aged 53 to 71 years, comprising a control group.
INTERVENTIONS: Patients and control subjects were given an intravenous volume load of Ringer's acetate solution (12.5 mL/kg for 30 min). MEASUREMENTS: The plasma concentrations of C-reactive protein, interleukin-6, interleukin-8 (inflammatory parameters used as biochemical evidence of trauma), and VEGF were measured in patients the morning after the day of the surgery. The area under the curve (AUC) for the plasma dilution was calculated in response to the intravenous fluid. MAIN
RESULTS: VEGF concentration was tripled in the hip group (100.7 +/- 18.5 pg/L vs. 31.9 +/- 7.2 pg/L; p < 0.001) as a consequence of the trauma of surgery. The other inflammatory parameters were also significantly increased. There was no difference in AUC between the two groups during infusion, but after infusion AUC was significantly increased in the hip group versus controls (4.88 vs. 2.8; p = 0.025), suggesting persistence of the infused fluid to remain in the vasculature. AUC was not highly correlated with any of the inflammatory parameters regardless of group during or after infusion.
CONCLUSIONS: Intravascular persistence of infused crystalloid is increased after hip surgery despite elevated VEGF levels in plasma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15567647     DOI: 10.1016/j.jclinane.2003.12.008

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  6 in total

Review 1.  Vascular precursor cells in tissue injury repair.

Authors:  Xin Shi; Weihong Zhang; Liya Yin; William M Chilian; Jessica Krieger; Ping Zhang
Journal:  Transl Res       Date:  2017-02-21       Impact factor: 7.012

2.  Persistent elevation of plasma vascular endothelial growth factor levels during the first month after minimally invasive colorectal resection.

Authors:  A Belizon; E Balik; P Horst; D Feingold; T Arnell; T Azarani; V Cekic; R Skitt; S Kumara; R L Whelan
Journal:  Surg Endosc       Date:  2008-01-18       Impact factor: 4.584

Review 3.  Fracture mortality: associations with epidemiology and osteoporosis treatment.

Authors:  Sebastian E Sattui; Kenneth G Saag
Journal:  Nat Rev Endocrinol       Date:  2014-08-05       Impact factor: 43.330

4.  Potential mediators of the mortality reduction with zoledronic acid after hip fracture.

Authors:  Cathleen S Colón-Emeric; Peter Mesenbrink; Kenneth W Lyles; Carl F Pieper; Steven Boonen; Pierre Delmas; Erik F Eriksen; Jay Magaziner
Journal:  J Bone Miner Res       Date:  2010-01       Impact factor: 6.741

5.  Accelerated care versus standard care among patients with hip fracture: the HIP ATTACK pilot trial.

Authors: 
Journal:  CMAJ       Date:  2013-11-18       Impact factor: 8.262

6.  Rationale and design of the HIP fracture Accelerated surgical TreaTment And Care tracK (HIP ATTACK) Trial: a protocol for an international randomised controlled trial evaluating early surgery for hip fracture patients.

Authors:  Flavia K Borges; Mohit Bhandari; Ameen Patel; Victoria Avram; Ernesto Guerra-Farfán; Alben Sigamani; Masood Umer; Maria Tiboni; Anthony Adili; John Neary; Vikas Tandon; Parag K Sancheti; AbdelRahman Lawendy; Richard Jenkinson; Mmampapatla Ramokgopa; Bruce M Biccard; Wojciech Szczeklik; Chew Yin Wang; Giovanni Landoni; Patrice Forget; Ekaterine Popova; Gavin Wood; Aamer Nabi Nur; Bobby John; Paweł Ślęczka; Robert J Feibel; Mariano Balaguer-Castro; Benjamin Deheshi; Mitchell Winemaker; Justin de Beer; Richard Kolesar; Jordi Teixidor-Serra; Jordi Tomas-Hernandez; Michael McGillion; Harsha Shanthanna; Iain Moppett; Jessica Vincent; Shirley Pettit; Valerie Harvey; Leslie Gauthier; Kim Alvarado; P J Devereaux
Journal:  BMJ Open       Date:  2019-05-01       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.